Objective: Given excellent 30-day survival for pediatric cardiac surgery, other outcome measures are important. We aimed to study important early postoperative morbidities selected by stakeholders following a rigorous and evidencedbased process, with a view to identifying potential risk factors.
INTRODUCTION What Is Pediatric Cardiac Surgical Morbidity?
Pediatric cardiac surgical morbidity is illness or lack of health that occurs soon after a cardiac operation, and so may be regarded as an adverse outcome of surgery. Although there has been considerable research on measuring, understanding, and reducing perioperative mortality, 1-3 there has been less attention on surgical morbidities.
Why Does Morbidity After Pediatric Cardiac Surgery Matter?
Previous research on surgical morbidities after pediatric cardiac surgery has established their association with longer stays in hospital and other adverse outcomes, including death. 4, 5 For children with some heart conditions, prolonged postoperative stay in hospital is associated with higher levels of long-term neurologic disability. 6 Prolonged hospitalization due to morbidities can be expensive to manage, for example, extracorporeal life support (ECLS) costs more than £10,000 per day. 7 Morbidity, disability, and quality of life are viewed as key outcomes by patients, families, and clinical teams who are looking to deliver further improvements in service quality. In the United Kingdom, a recent major review of the specialty highlighted the need to monitor a range of outcomes including morbidity in a timely and meaningful fashion, 8 and commissioners of services are appropriately seeking evidence on outcomes and quality assurance from providers.
Our Study
In previous work, a multidisciplinary group with patient and caregiver involvement selected a list of 9 key early postoperative morbidities 9 that they considered most important, informed by clinical views on definitions and feasibility of routine monitoring. 10 The selection process set out to identify the morbidities likely to have the greatest impact on patients in terms of hospital stay, mortality, quality, and cost (to be measured in a subset of patients and presented separately). Morbidities considered likely to have a lower impact or to be rare or difficult to reliably define and measure were not included.
The selected morbidities were ECLS, acute neurologic event, unplanned reintervention, feeding problems, major adverse event, prolonged pleural effusion, postsurgical infection morbidity, renal support, and necrotizing enterocolitis. A report detailing the definitions for each of these morbidities has been peer reviewed and published previously, 10 and we include the main table from Brown and colleagues 10 as Appendix E1. We report the incidence of and risk factors for these morbidities within the UK pediatric cardiac surgery population.
MATERIALS AND METHODS Patient Population
Our study population comprised all children aged less than 17 years undergoing cardiac surgery and open, closed, or hybrid procedures involving the heart as specified by the National Congenital Heart Disease Audit (NCHDA) 11 at each of 5 participating centers between October 1, 2015, and June 30, 2017, other than premature babies undergoing persistent ductus arteriosus ligation (who are mainly cared for in neonatal intensive care units) and children undergoing cardiothoracic transplant or tracheal procedures. These exclusions were made because these groups experience different sets of morbidities, and furthermore because of centralization of services in the United Kingdom, tracheal and transplant procedures are only carried out in one of the study sites. The participating centers care for approximately more than half of children with cardiac disease in the United Kingdom. 11 
Data Collection
Patients were prospectively monitored for the presence of the 9 early morbidities selected 9 and defined 10 in previous work as important and suitable for routine monitoring.
Data collection was undertaken prospectively, and morbidities were attributed to the immediately preceding cardiac surgery and defined within the same hospitalization other than unplanned reoperation within 30 days (an unanticipated cardiac procedure within 30 days was a morbidity outcome; Appendix E1 ,10 shows details) and mediastinitis (falls within postoperative infection morbidity, Brown and colleagues, 10 and Appendix E1 shows details), both of which could be identified postdischarge by the operating surgeon and clinical care team.
As for the UK audit of 30-day mortality, 12 procedures on the same patient were included in the analysis of morbidity incidence if they occurred more than 30 days apart (ie, a new procedure occurring more than 30 days after the first or index operation was considered a separate clinical episode of care and included in the analysis as such). Planned operations within 30 days did not contribute to the analysis.
We obtained key clinical data on study patients from the local copy of NCHDA 11 data held at each study site. All data were pseudonymized before sending them to the study team for analysis. The advantage of harnessing NCHDA data for this study was that each field is clearly and consistently defined. It is mandatory to record every cardiac procedure, and NCHDA data overall are externally validated.
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At the end of the study, we cross-checked the study population with NCHDA, removed operations that should have been excluded (eg, elective chest closures, miscoded interventional catheters), and verified all reoperation morbidities, including double-checking any ambiguous reoperations with the operating surgeon.
Candidate Risk Factor Variables and Variable Groups
We prespecified candidate clinical risk factors 12, 13 in the peer-reviewed study protocol. Most candidate risk factors were selected on the basis of previous known empiric association with mortality after pediatric cardiac surgery [12] [13] [14] supplemented by a small number of candidate variables considered clinically important (sex, Down syndrome, prematurity).
The candidate risk factors considered in our analyses were sex, age band (neonate, infant, child), 12 calculated weight-for-age z-score, 15 cardiac diagnosis category, functionally univentricular heart (yes/no), specific procedure type category, operation type (bypass, nonbypass, or hybrid), bypass time, acquired comorbidity, congenital comorbidity excluding Down syndrome, Down syndrome, additional cardiac risk factors, prematurity, and severity of illness indicator. 12 We previously published the method by which the broad comorbidity groups that we used in this analysis were derived from 776 individual conditions. 16 In this study, we used exactly the same comorbidity groups as in Brown and colleagues, 16 and we summarize these in Table 1 . For the variables of cardiac diagnosis and cardiac surgical procedure, we noted that there were many variables leading to some categories being sparsely populated. Therefore, these 2 variable groups were collapsed further to help with clinical interpretation. All subcategorizations were undertaken with reference to empiric data on risk of early mortality. 1, [12] [13] [14] These categorizations are summarized in Table 1 , and details of how our previously published categories from Rogers and colleagues 12 were collapsed for this study of morbidity are provided in Appendix E2.
Data Cleaning and Validation
To ensure accuracy of study data and complete case ascertainment for incident morbidities, we took the following steps:
A monthly telephone conference call involving at least 1 person from all sites discussed any ambiguous cases, and final case ascertainment was agreed. A 3-month sample of data from each study site (January 1, 2016, to March 31, 2016) was checked against an independent data source, NCHDA, for 5 of the morbidities. A final reconciliation of morbidities was undertaken at the end of the study when any cases with incomplete morbidity data were reviewed by the dedicated research nurse and a senior clinician at the sites.
Sample Size
In the original study protocol, we anticipated that between 3000 and 3300 surgical patients would be included across the 5 sites. 11 On the basis of morbidity rates from a previous study, we calculated that this was sufficient to estimate accurately the incidence for morbidities occurring in at least 2% of cases. In the event the incidence in isolation was less than 1.5% for 5 of the morbidities, this meant that for analysis of risk factors for the primary morbidity outcome we needed to group morbidities for statistically robust analysis.
Primary Outcome
We used the following groupings of morbidity outcome for risk factor analysis:
Two categories-any morbidity versus none of the selected morbidities, analyzed using multilevel logistic regression, accounting for multiple procedures within patients. Specific cardiac procedure categories NCHDA developed an algorithm for grouping pediatric cardiac operations into relatively homogeneous procedure categories for reporting mortality outcomes. 11 To develop models with risk factors for the outcome of morbidity, we collapsed these 50 procedure groups (includes not a procedure grouping) into 3 broad categories of reparative or corrective operation, palliative or staging operation, and ungrouped operation (where the approach could not be determined) (Appendix E2).
Comorbidity categories
To develop models with risk factors for the outcome of morbidity, we included the preexisting comorbidity groups developed for pediatric cardiac procedures 16 that appear as independent risk factors for mortality in the UK-based risk adjustment model for 30-d mortality after pediatric cardiac surgery. 12 These are (1) acquired comorbidity (eg, renal failure, stroke), (2) congenital comorbidity excluding Down syndrome (eg, congenital defect of a major organ or genetic syndrome), (3) additional cardiac risk factors (eg, cardiomyopathy, pulmonary hypertension), and (4) severity of illness indicator (eg, preprocedure respiratory failure or shock). We also included for consideration of any link to morbidity (5) Down syndrome and (6) prematurity (gestational age<37 wk), although they were not statistically linked to postoperative mortality. 12 Four categories-no selected morbidity, single selected morbidity other than ECLS; multiple morbidity with no ECLS; and ECLS. This grouping of outcomes enables the discrimination of risk factors for the particularly adverse outcomes of ECLS and multiple morbidities as identified a priori. [17] [18] [19] [20] [21] 
Analysis of Risk Factors for Primary Outcome
The prevalence of candidate risk factors is described with frequency (%) for categoric factors and mean (standard deviation [SD]) or median (interquartile range) as appropriate for continuous factors. For the outcome of any selected morbidity versus no selected morbidity, the estimated effects are presented as odds ratios (ORs) and 95% confidence intervals (CIs).
For the 4 category morbidity outcomes, we used multinomial logistic regression with robust standard errors to adjust for clustering within patients. Estimated effects are presented as risk ratios (RRs) and 95% CI. For both outcome groupings, we investigated whether the inclusion of site as a random factor was important.
For both outcome groupings, univariate models were fitted for each of the prespecified candidate risk factors, and the estimated effects of the factors on morbidity outcome are presented along with 95% CIs. All factors significant on univariate analysis (P <.1) were included in the multivariable models. We state the number of missing values where relevant in results. We used multiple imputation by chained equations to account for missing data, and the imputation model included all risk factors considered in the univariate analysis, which we assumed to include all predictors of whether a data item would be missing. The final multivariable models were derived by fitting a regression model for all significant predictors, and estimates were combined using Rubin's rules. 22 Model performance for the final multivariable models was assessed using the c-statistic (area under the receiver operator curve) and Hosmer-Lemeshow statistic. All analyses were performed in Stata 14. 23 
Secondary Outcomes
The life status of patients in the study at 6 months after each operation was determined using a combination of hospital records and NCHDA data in March 2018. Thirty-day and 6-month mortality were attributed to the first appearance of each patient in the dataset.
Length of stay was defined as the number of whole days between the operation that led to the child entering the study and the date of discharge from the specialist cardiac center. Two data sources (study database and NCHDA) were cross-checked for accuracy.
Mortality within 6 months of each patient's first procedure was compared between patients with and without a morbidity using logistic regression.
RESULTS

Descriptive Data
After removal of 10 misclassified procedures (minor and excluded procedures, such as chest reopenings), 63 cardiac operations that were undertaken within 30 days as part of the planned treatment pathway, and all unplanned reoperations within 30 days (a morbidity outcome, Table 2 , there were 161 in total), there were 3090 procedures meeting inclusion/exclusion criteria. These procedures pertained to 2861 patients, of whom 2648 had 1 surgical procedure, 197 had 2 surgical procedures, and 16 had 3 surgical procedures.
Of the 3090 procedures included in the study, 1723 (56%) were reparative, 510 (16%) were palliative, and 857 (28%) were ungrouped. Of these procedure episodes, 414 (13.4%) were in functionally univentricular circulations, 528 (17.1%) were in neonates, 1291 (41.8%) were in infants, and 1271 (41.3%) were in children.
There was excellent concurrence between the study data set and NCHDA; among the 443 patients in the 3-month sample checked, 9 morbidities were present in the study dataset but not in NCHDA, and in no cases was a morbidity recorded in NCHDA and not in the study dataset.
Incidence of Morbidities
We present the incidence of individual selected morbidities as ''any occurrence'' (the total number of occurrences of a given morbidity both as part of a multi-morbidity and as a standalone event) and ''in isolation'' (where the morbidity occurred as a stand-alone event) in Figure 1 and Table 2 . Given that we had an a priori interest in ECLS as a severe adverse event, when ECLS occurred, patients were defined as ECLS morbidity irrespective of other concurrent morbidities. The most common morbidities as ''any occurrence'' were prolonged pleural effusion (6.5%), feeding problems (6.0%), and unplanned reintervention (5.2%). We prespecified in the protocol that morbidities with a rate less than 1.5% could be considered rare. All of the 9 selected morbidities had any occurrence rate greater than 1.5%, the least common being an acute neurologic event (2.1%). However, only 4 morbidities occurred in isolation at a rate greater than 1.5%: prolonged pleural effusion, feeding problems, unplanned reintervention, and ECLS.
Multiple Morbidities
Of 197 (6.4%) procedures that resulted in multiple morbidity, 76 (39%) were with a feeding problem, 73 (37%) with an unplanned reintervention, 72 (37%) with prolonged pleural effusion, 67 (34%) with major adverse event, 66 (34%) with renal support, 49 (25%) with postsurgical infection, 34 (17%) with acute neurologic event, and 33 (17%) with necrotizing enterocolitis. For the 197 multiple morbidity cases, 140 involved 2 morbidities, 39 involved 3 morbidities, 17 involved 4 morbidities, and 1 involved 5 morbidities.
ECLS Morbidities
Among the 62 (2%) procedures in which there was postoperative ECLS, only 6 involved just ECLS and no other morbidities, 37 (60%) ECLS morbidities involved renal support; 33 (53%) were with major adverse event, 29 (47%) were with unplanned reintervention, 19 (31%) were with prolonged pleural effusion, 16 (29%) were with an acute neurologic event, 10 (16%) were with necrotizing enterocolitis, 9 (15%) were with postsurgical infection, and 9 (15%) were with a feeding problem. Table 3 shows the frequency (%) for categoric risk factors and mean (SD) or median (interquartile range) as appropriate for continuous risk factors. Weight was missing or infeasible (>5 SD from the normative mean) in 186 patients, and for these we used multiple imputation to infer their weight. Multi-morbidity category and the 9 single morbidities Any morbidity (single or as part of a multi-morbidity) FIGURE 1. Incidence of selected morbidities by procedure with 95% CIs. 1, In red, all instances of each of the defined morbidities including as single morbidities, as part of multi-morbidities and as part of ECLS. 2, In blue, the numbers for each of the defined morbidities when these occurred in isolation.
Risk Factors for Occurrence of Any Morbidity Versus No Morbidity
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With the exception of patient sex, prematurity, Down syndrome, and low weight for age, all candidate risk factors were statistically associated with any morbidity outcome in multivariable analysis (Table 3 shows ORs and 95% CIs). Inclusion of site made a negligible difference, and we present results from the model without site. After adjustment for other factors, age was the most important risk factor: Neonates had a 5.26-fold increased chance of morbidity, and infants had a 1.61-fold increased risk compared with children aged more than 1 year. Cardiac diagnosis group was the next most influential factor, with the more complex conditions carrying a higher risk of morbidity, followed by a prolonged bypass time in excess of 90 minutes, which carried a 2.8-fold increased risk. A palliative or staged procedure and the presence of a functionally univentricular heart both increased the chance of a morbidity 1.6 times (these 2 factors clearly have some overlap). Severity of illness factor (which includes preprocedure mechanical ventilation or shock) increased the risk by 1.5 times.
The area under the receiver operator curve for the final multiple logistic regression model for any morbidity was 0.77 (95% CI, 0.75-0.79), and Hosmer-Lemeshow goodness of fit was P ¼ .13, indicating reasonable calibration of the model.
Risk Factors for the 4-Level Morbidity Outcome
The multinomial models for the 4-category outcome are shown in Table 4 . These analyses were in line with the 2) and 4.5 (95% CI, 2.4-8.5) for multiple morbidities, suggesting these were strongly linked to these outcomes. The next most important risk factor for both these outcomes was prolonged bypass time more than 90 minutes. In particular, this was associated with a 6.6-fold risk of ECLS, noting that this intraoperative measure may reflect unexpected findings or technical challenges at operation. Increased severity of illness (which includes preprocedure mechanical ventilation or shock) was associated with a 3.7-fold higher incidence of ECLS and a 1.7fold risk for multiple morbidities. However, we advise some caution in interpreting these results because the number of ECLS patients was relatively low and CIs are wide. Surgical procedure category and univentricular heart were not significant risk factors in this model.
Secondary Outcomes
There were 9 patients discharged alive for whom life status information at 30 days was unavailable. Life status at 6 months was unavailable for 7 patients; these patients are not included in the corresponding mortality results. Missing date information for 9 patients led to them being excluded from the length of stay analyses.
Of 2861 patients, 37 (1.3%) died within 30 days and 89 (3.1%) died within 6 months of their first procedure. Postoperative length of stay, 30-day survival, and 6-month survival are shown in Table 5 by individual morbidity type. Given that these were secondary outcomes, not subjected to detailed risk modeling and included for descriptive purposes, we do not present P values with this table. Postoperative length of stay is depicted in Figure 2 .
While acknowledging that we did not undertake detailed risk models for our secondary outcomes of survival 6 months after operation and patient length of stay (both are linked to case complexity), we note that these measures were strongly associated with morbidity. The 6-month survival was significantly higher in those who had no selected morbidity at 99.3% (95% CI, 98.9-99.6) than those who had ''any morbidity'' at 88.2% (95% CI, 85.4-90.6; P < .001). Patients with any single selected morbidity, ECLS, or multi-morbidity had a significantly lower survival at 6 months compared with those with no selected morbidity (P <.001). All morbidity groups had a significantly longer length of stay than patients with no selected morbidity.
DISCUSSION
This unique, large prospective multicenter study of the incidence of important early morbidities after pediatric cardiac surgery highlights some important points. Among 3090 procedures, 21.8% led to at least 1 of the selected morbidities. Of these 3090 procedures, 6.4% led to multiple morbidities and a further 2% led to ECLS, which in particular may be considered a near-miss adverse event. The most common of our included morbidities, all with rates greater than 5%, were prolonged pleural effusion, feeding problems, and unplanned reoperation.
The patients who had none of the selected morbidities had shorter lengths of stay than those with 1 or more of the selected morbidities and were more likely to survive to 6 months. Although patients with 1 or more selected morbidity were more complex, the large differences we report in length of stay and survival at 6 months with morbidity emphasize the importance of these events for patients and families, and as potential future metrics for benchmarking.
The most important risk factors for the selected morbidities, as has been shown in previous studies [24] [25] [26] included nonmodifiable risk factors of young age and more complex cardiac diseases. In addition, children who deteriorated before surgery requiring intensive care supports with severity of illness factors, which may in some instances be modifiable, were more likely to experience morbidity. Prolonged cardiopulmonary bypass time, which again in some cases be modifiable, was particularly associated with the key outcomes of ECLS and multiple morbidities.
Our study complements the findings of a number of initiatives that illustrate growing attention worldwide on the issue of surgical morbidity in this population, although a notable difference in our study was the selection of a list of morbidities incorporating perspectives from families and clinicians working outside specialist centers. 9 Moreover, our stated remit was to include morbidities that were considered important based on prevalence and impact, rather than an exhaustive list of every morbidity. We note other important initiatives including activities of the Society of Thoracic Surgeons Taskforce Subcommittee on Patient Safety, which defined a range of unwanted events that may contribute to postoperative morbidity, including complications, adverse events, harm, medical error or injury, and near misses. 27 Investigators used Society of Thoracic Surgeons Registry data to develop a composite scores to measure morbidity. 25 A concern with this approach is that specific morbidities that may be amenable to quality improvement are less visible.
Prospective efforts include a Canadian study, which indicated that prospective monitoring of complications may lead to greater case ascertainment and thus a perception of higher complication rates. 24 The Pediatric Cardiac Critical Care Consortium (PC 4 ) set up in 2009, with the aim to improve the quality of care to patients with critical pediatric and congenital cardiovascular disease in North America and abroad, provides partner sites who participate on a voluntary basis with access to contemporary data for quality improvement. 28, 29 A motivation for our study was that although routine audit of postoperative mortality in pediatric cardiac surgery is well established in the United Kingdom via the NCHDA, 11 stakeholders, including children's heart surgery programs, congenital heart patient support groups, and the national audit, want to add morbidity outcomes to the current reporting of mortality. In 2015 at the start of our study, the NCHDA initiated the capture of preliminary morbidity measurements based on our study protocols, but these outcomes have yet to be analyzed. The collection of morbidities by the NCHDA will over time enable a future registry-based study involving larger numbers of patients, which might enable a method of risk adjustment and national audit to be developed for routine use.
Study Limitations
We included only risk factors for morbidity that were available within mandatory and validated national audit data. Although this means that centers can analyze their ongoing case-mix with respect to these factors, we acknowledge that there may be other risk factors that we have not identified by taking this approach. It was necessary to collapse the risk factors of cardiac diagnosis and cardiac procedure into broad groups for our risk factor analyses, thus limiting interpretation of our results when considering specific individual conditions or procedures. Of note, we took an approach of categorizing cardiac procedures into 3 broad groups and cardiac diagnosis into 5 groups. We think cardiac diagnosis is an important factor to consider in outcome analyses because we recognize that the most complex patients may undergo a series of operations. Although we undertook extensive quality checks on our study data, no such processes are perfect. We found low rates for certain morbidities as stand-alone events, and the small numbers limited the risk factor analysis we were able to undertake for these individual stand-alone morbidities, for example, we did not have sufficient numbers to analysis incidence by specific procedure.
CONCLUSIONS
Our prospective multicenter study from the United Kingdom complements the international efforts in this important area. To assist with audit and quality assurance initiatives, we have developed software for local monitoring of complication rates in the United Kingdom, and we have co-developed information resources related to these findings for parents who report on rates of the selected morbidities, which will be available to UKbased clinicians to use during the surgical consent process. In the future, it is hoped that routine collection of important morbidity measures will complement the collection of mortality data by the national congenital heart diseases audit in the United Kingdom.
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Discussion
Dr Meena Nathan (Boston, Mass). You have involved multiple people to come up with your 9 important comorbidities, and it is important in future studies that key stakeholders be involved early in the process, and I congratulate you on doing that in a timely fashion. I have several questions for you. In your morbidity analysis, you analyzed on the basis of procedures rather than at the patient level. How many of those 3090 procedures occurred during the same hospitalizations? Were there any that were counted twice during the same hospitalization?
Dr David Barron (London, United Kingdom). They would have to have occurred during the hospital admission to be counted as a morbidity. Dr Nathan. My question was, you had 2861 patients but 3090 operations. Dr Barron. Procedures, yes. Dr Nathan. How do you account for that?
Dr Barron. Of course, some of them were the same patients, such as a staged Norwood, they may have had their stage I and II during the period of the study so they would appear twice. If they had a reoperation during the same admission and if it was within 30 days, it would not count as a separate procedure. So you have to have 2 procedures at least 30 days apart for them to be entered.
Dr Nathan. Were there some that occurred during the same hospitalization?
Dr Barron. Yes.
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Dr Nathan. How do you account for which morbidity went with which procedure?
Dr Barron. It goes back to the primary procedure in that case.
Dr Nathan. You had a large sample size. I was wondering whether you considered additional subgroup analysis on the higher risk groups, such as neonates and maybe on palliative versus nonpalliative procedures?
Dr Barron. Yes, that is all in process now, so there is a lot of additional analysis that goes into particulars for each individual morbidity where we are studying the risk factors for each individual morbidity and how it is affecting survival.
Dr Nathan. And you did do a clustered analysis to account for center variation?
Dr Barron. Yes. Dr Nathan. Did you consider analyzing volume of surgeon, volume of center as tertiles to look at variability?
Dr Barron. Exactly that, and we are doing it. There is surprisingly little variation between the centers, but the full analysis is still to come out. There are some real lessons. For instance, we don't understand why but in Birmingham we have a low incidence of need for renal support. So we are intrigued to look into these sort of things that the study has thrown up to see whether we can learn from each other and if there is anything differently that others can learn from.
Dr Nathan. Have you decided of these 9 which are the 5 you are going to prospectively monitor and audit at all your centers?
Dr Barron. It's the ones that are easiest to define and manage. So it's going to be need for renal support and for neurologic outcomes, a need for ECMO for unexpected reoperations during admission and for major adverse events.
Dr Yves d'Udekem d'Acoz (Victoria, Australia). David, I think it's great work. It is nice to have this large set of data. I want to challenge you a bit and see how do you practically react to that? You have got your little app and what do you do from there? Do you go to your guys and say, hey, guys, your rate of stroke is high, your babies are not feeling well, you have to do something. And then there are some measurements that are not the same as the other ones, and I was particularly happy to look at the rate of unplanned reoperation, 5%, which is what I estimate it should be. I am nervous when people tell me that they have a low rate of reoperation, because you want to ultimately have the patient get out of the hospital with a perfect operation even if it is at the cost of a reoperation.
Dr Barron. Very well said, good, you are quite right, we look at these things, but what are we going to do about it? I think for some of them they might at least focus everybody on the fact that things aren't going as well as you might think things are going. Things like infection rates, for sure, I think you can react to them and do something about it. For some of the others it may not necessarily be so easy, but at least it heightens your awareness, and I think at least you are armed a little bit with more information.
For reoperations, it's difficult to standardize for it because people's thresholds for reoperation will be different and you don't quite know, as you say, when it becomes a good thing or a bad thing. So we will be going into the whole analysis and looking at all the patients who had reoperations to try and make sort of an understanding of whether it reflected bad practice or whether it reflected good practice. Feeding problems A diagnosis of postoperative feeding problems should be considered during recovery after surgery and before discharge from the specialist center to home or to secondary care if the child is unable to feed normally. The goal is detection of feeding problems which are new postsurgery, and it is recognized that this may be challenging where a child A child may fail to feed normally after pediatric cardiac surgery for a range of reasons including gastroesophageal reflux, vocal cord paralysis, oralmotor dysfunction, oral aversion, and neurologic impairment. E2 If for any of these reasons a child is not able to orally feed or completely orally feed and is tube dependent at discharge from the tertiary
APPENDIX
The requirement for any feeding support. Includes via the intravenous route or via an enteral tube. Excludes feeding support that was present to treat a primary problem diagnosed before the surgery, feeding support related to an episode of necrotizing enterocolitis, and feeding support because the child dislikes a special diet. 
Minimum treatment protocol
was not fed preoperatively for cardiac reasons because feeding ability will not have been assessed objectively.
center or at 30 d (if he or she is otherwise clinically stable enough to feed at that time point), then a postoperative feeding problem will be diagnosed.
Need for renal replacement therapy
Includes renal replacement therapy when initiated as a new support at any time from the start of the postoperative admission to ICU up to 30 d after the primary operation.
The child requires renal replacement therapy (peritoneal dialysis or hemofiltration) for renal failure (oligo-anuria of < 0.5 mL/kg/h and elevated creatinine level for age) or fluid overload. In patients in whom renal support is required alongside ECLS, the primary morbidity is viewed as ECLS.
The measurement protocol is simply the presence of (new) renal support.
(Excludes renal support on ECLS.) Data on renal biochemistry and urine output will be collected. prolonged antibiotic therapy.
Prolonged pleural effusion or chylothorax
Prolonged pleural effusion is a postprocedural effusion with duration >10 d. Chylothorax is diagnosed from after surgery until discharge from the tertiary hospital.
Either a chylous pleural effusion or significant chylous pericardial effusion or significant chylous ascites or a prolonged nonchylous effusion that necessitates thoracic drainage at least 10 d after index cardiac surgery.
Chylous effusions are characterized by milky appearance and a pleural fluid white blood cell count of greater than 1000 cells/ mL with lymphocytes greater than 80%. E7 If the child is on normal feeds the triglyceride level in the pleural fluid will be > 1.1 mmol/L or the ratio between the pleural triglyceride level and the serum triglyceride level will exceed 1. 
